Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
10000 participants
INTERVENTIONAL
2020-10-26
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characteristics of NAFLD Among Type 2 Diabetes Patients
NCT04999124
Prevalence of NAFLD in T2DM Patients
NCT06445335
Lifestyle Guidance Methods in NAFLD
NCT05792488
Determinants of Liver Fat Composition
NCT03211299
Fatty Liver Disease in Nordic Countries
NCT04340817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
participants
screening
The determination of the prevalence of NAFLD in a general population in Flanders, Belgium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
screening
The determination of the prevalence of NAFLD in a general population in Flanders, Belgium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to understand Dutch,
* able to understand the informed consent
Exclusion Criteria
* excessive alcohol abuse
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geert Robaeys
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert Robaeys, prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Leen Heyens, drs.
Role: STUDY_CHAIR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasselt University
Hasselt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCREEFLAN-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.